comparemela.com

Latest Breaking News On - Gsk ln - Page 5 : comparemela.com

Sanofi Will Carve Out Consumer Health Division in Bid to Invest More in Science

The stand-alone division will be the latest addition to a growing list of such public companies recently spun out of larger drugmakers.

France generalUnited statesJosh nathan kazisPaul hudsonThomas samsonBoehringer ingelheimCenters for diseaseGetty imagesDisease controlArticle normalCosmetics toiletriesHealthcare life sciencesConsumer goodsPersonal care products appliancesCorporate industrial newsBiotech and pharma

GSK and Other Companies Push Forward With RSV Vaccine Amid Shortages

The U.K. drugmaker GSK is seeking to expand regulatory approval for its new respiratory syncytial virus vaccine to include younger adults.

United statesTony woodJosh nathan kazisKsenia kuleshova bloombergAkash tewariCenters for diseaseDisease controlArticle normalRetail wholesaleHealthcare life sciencesSpecialized drugs medicationsRegulation government policyNew products servicesProduct service approvalsCorporate industrial newsProducts services

GSK Strikes $3 06 Bln Shingles Vaccine Deal With China s Zhifei -- Update

By Michael Susin GSK said that Chongqing Zhifei Biological Products has agreed to purchase the company's shingles vaccine Shingrix under an exclusive.

United kingdomMichael susinChongqing zhifei biological productsArticle normalHealthcare life sciencesSpecialized drugs medicationsPolitical general newsMedical treatments procedures300122 szCn 300122Gsk lnUk gskGeneral newsMedical treatmentsLife sciencesSpecialized drugs

GSK Raises $1 08 Bln From Sale of Haleon Shares

By Elena Vardon GSK said it raised 885.6 million pounds ($1.08 billion) from the sale of some of its shares in Haleon, reducing its stake in the.

United kingdomElena vardonArticle normalHealthcare life sciencesHln lnUk hlnGsk lnLife sciences

GSK Plans to Reduce Stake in Haleon

By Christian Moess Laursen GSK said its plans to sell 270 million of shares in Haleon, taking its stake to around 7.4%. The British pharmaceutical giant said.

United kingdomChristian moess laursenChristian moessArticle normalHealthcare life sciencesCorporate strategy planningOwnership changesAcquisitions mergers shareholdingsCorporate actionsCorporate industrial newsContent typesFactiva filtersC amp ampe industry news filterHln lnUk hlnGsk ln

vimarsana © 2020. All Rights Reserved.